Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested â papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: âIbrutinibârituximab followed by R-HCVAD as frontline treatment for young patients (â€65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trialâ.
Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Loretta J. Nastoupil, Luis Fayad +32 more